BKD:NYE-Brookdale Senior Living Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 5.13

Change

+0.06 (+1.18)%

Market Cap

USD 1.11B

Volume

1.07M

Analyst Target

USD 4.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding, single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment also operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It also manages communities on behalf of others. Brookdale Senior Living Inc. was incorporated in 2005 and is headquartered in Brentwood, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-1.86 (-0.61%)

USD 76.91B
DVA DaVita HealthCare Partners Inc

+0.48 (+0.31%)

USD 13.14B
THC Tenet Healthcare Corporation

-1.76 (-1.36%)

USD 12.31B
UHS Universal Health Services Inc

-0.09 (-0.05%)

USD 11.60B
EHC Encompass Health Corp

+0.17 (+0.18%)

USD 9.52B
CHE Chemed Corp

+2.75 (+0.53%)

USD 7.84B
CON Concentra Group Holdings Paren..

+0.12 (+0.59%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.62 (+3.86%)

USD 2.59B
NHC National HealthCare Corporatio..

+0.47 (+0.42%)

USD 1.90B
AMN AMN Healthcare Services Inc

+0.71 (+3.04%)

USD 1.00B

ETFs Containing BKD

DXSD:F 10.59 % 0.00 %

N/A

N/A
DXSD:XETRA 10.59 % 0.00 %

N/A

N/A
ESIE:LSE iShares MSCI Europe Energ.. 10.53 % 0.00 %

N/A

USD 0.12B
ESIE:XETRA iShares MSCI Europe Energ.. 10.39 % 0.00 %

N/A

USD 0.15B
STNX:SW SPDR® MSCI Europe Energy.. 9.07 % 0.00 %

N/A

USD 0.79B
EYED:LSE iShares MSCI Europe Energ.. 9.01 % 0.00 %

N/A

N/A
ENGE:LSE SPDR® MSCI Europe Energy.. 7.90 % 0.00 %

N/A

N/A
SXEPEX:SW iShares STOXX Europe 600 .. 6.85 % 0.00 %

N/A

USD 0.08B
CSMIB:SW iShares VII PLC - iShares.. 6.56 % 0.00 %

N/A

N/A
AJEUAS:SW UBS (Irl) Fund Solutions .. 3.04 % 0.00 %

N/A

N/A
EEI:SW 2.11 % 0.00 %

N/A

N/A
EEIA:SW WisdomTree Europe Equity .. 2.11 % 0.00 %

N/A

N/A
VALD:SW BNP Paribas Easy ESG Equi.. 2.04 % 0.00 %

N/A

USD 3.59M
EWI iShares MSCI Italy ETF 0.00 % 0.47 %

+0.12 (+0.00%)

N/A
MIBX:LSE Lyxor UCITS FTSE MIB 0.00 % 0.00 %

N/A

N/A
UC14:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

N/A
UC15:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

N/A
UC90:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.01B
XD3E:LSE Xtrackers Euro Stoxx Qual.. 0.00 % 0.00 %

N/A

USD 0.24B
FMI:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.06B
MIB:PA Lyxor FTSE MIB (DR) UCITS.. 0.00 % 0.00 %

N/A

USD 0.40B
STN:PA SPDR® MSCI Europe Energy.. 0.00 % 0.00 %

N/A

USD 0.77B
ELFC:F Deka EURO iSTOXX ex Fin D.. 0.00 % 0.00 %

N/A

N/A
EXH1:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
SPYN:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
DXSA:XETRA Xtrackers - Euro Stoxx Se.. 0.00 % 0.00 %

N/A

USD 0.26B
DBXI:XETRA Xtrackers FTSE MIB UCITS .. 0.00 % 0.00 %

N/A

USD 0.05B
EXH1:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.73B
SPYN:XETRA SPDR® MSCI Europe Energy.. 0.00 % 0.00 %

N/A

USD 0.99B
SXRY:XETRA iShares FTSE MIB UCITS 0.00 % 0.00 %

N/A

USD 0.21B
UIQI:XETRA UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.31B
UC48:LSE UBSs plc - MSCI AC Asia E.. 0.00 % 0.00 %

N/A

USD 0.26B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.86% 35% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.86% 35% F 15% F
Trailing 12 Months  
Capital Gain -14.21% 35% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.21% 30% F 14% F
Trailing 5 Years  
Capital Gain -26.82% 28% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -26.82% 28% F 13% F
Average Annual (5 Year Horizon)  
Capital Gain 32.68% 78% C+ 88% B+
Dividend Return 32.68% 70% C- 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 71.02% 30% F 13% F
Risk Adjusted Return 46.02% 78% C+ 61% D-
Market Capitalization 1.11B 57% F 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector